http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090038025-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c788de0c3305c75b47487c85a2728867 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22 |
| filingDate | 2007-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed79a79784396dd6a627fb7983f0f751 |
| publicationDate | 2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090038025-A |
| titleOfInvention | Implants for transplantation that are particularly useful for tissue reinforcement and scar formation |
| abstract | The present invention provides a modified globin material that is insoluble at natural or physiological pH and / or a material obtained from globin modified to be soluble at physiological pH, comprising: biodegradable and biocompatible materials in an organism; Natural or synthetic polymeric adhesive agents, polymeric tissue enhancement or filling agents, in particular those based on crosslinked hyaluronic acid or polylactic acid, and polymeric wound cicatrisation agents, in particular those selected from oxidized cellulose. Including; Provided that the polymeric cohesive agent is not hyaluronic acid or carboxymethyl cellulose, if present, and the polymer enhancing or filling agent, if present, is present if the formulation contains a material obtained from at least partially soluble globin. A drug based on crosslinked hyaluronic acid, wherein when the formulation contains oxidized cellulose, it is present on the organic tissue, which is present in a high proportion relative to the globin material, in this case a modified globin material that is insoluble at natural or physiological pH. Or sterile preparations which can be implanted therein; And in particular the use of such agents for filling or scar formation. |
| priorityDate | 2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.